Evaluation status available after sign-in
About the journal
Antibodies is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 1,800 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 2073-4468
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,800 CHF
- Articles in DOAJ
- 799
- Declared review time
- 6 weeks
- Declared peer-review model
- other
- Official website
- http://www.mdpi.com/journal/antibodies
Index listings
- DOAJ · 2012-11-29
- PUBMED · 2012-07-04
- Indexing
- DOAJ · PUBMED
- APC
- 1,800 CHF
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
799
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
846
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
57
i10-index
346
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-10
- Added to DOAJ
- 2012-11-29
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 94%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101587489
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
LCC codes
RC581-607
Subject areas
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Protein purification and stability
- Glycosylation and Glycoproteins Research
- Glycosylation and Glycoproteins Research
- Protein purification and stability
- Protein purification and stability
Show all subjects (75)
- T-cell and B-cell Immunology
- CAR-T cell therapy research
- CAR-T cell therapy research
- vaccines and immunoinformatics approaches
- Systemic Lupus Erythematosus Research
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Biosimilars and Bioanalytical Methods
- Cancer Immunotherapy and Biomarkers
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- Immunotherapy and Immune Responses
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Viral Infectious Diseases and Gene Expression in Insects
- Viral Infectious Diseases and Gene Expression in Insects
- Toxin Mechanisms and Immunotoxins
- Toxin Mechanisms and Immunotoxins
- Toxin Mechanisms and Immunotoxins
- vaccines and immunoinformatics approaches
- vaccines and immunoinformatics approaches
- Transgenic Plants and Applications
- Transgenic Plants and Applications
- Systemic Lupus Erythematosus Research
- Protein Structure and Dynamics
- Systemic Lupus Erythematosus Research
- Viral Infectious Diseases and Gene Expression in Insects
- Chemical Synthesis and Analysis
- Advanced Biosensing Techniques and Applications
- Complement system in diseases
- Glycosylation and Glycoproteins Research
- Advanced Biosensing Techniques and Applications
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- COVID-19 Clinical Research Studies
- Cancer Immunotherapy and Biomarkers
- COVID-19 Clinical Research Studies
- Systemic Sclerosis and Related Diseases
- Radiopharmaceutical Chemistry and Applications
- Complement system in diseases
- COVID-19 Clinical Research Studies
- Platelet Disorders and Treatments
- Complement system in diseases
- Platelet Disorders and Treatments
- Immune Cell Function and Interaction
- Cancer Immunotherapy and Biomarkers
- Vasculitis and related conditions
- Biosimilars and Bioanalytical Methods
- Animal Virus Infections Studies
- Galectins and Cancer Biology
- Biosimilars and Bioanalytical Methods
- Galectins and Cancer Biology
- Rheumatoid Arthritis Research and Therapies
- Bacteriophages and microbial interactions
- Cell Adhesion Molecules Research
- Chronic Lymphocytic Leukemia Research
- Cell Adhesion Molecules Research
- Chronic Lymphocytic Leukemia Research
- Bacteriophages and microbial interactions
- Autoimmune Neurological Disorders and Treatments
- Food Allergy and Anaphylaxis Research
- Renal Transplantation Outcomes and Treatments
Keywords (DOAJ)
- antibody-producing cells
- antibody engineering
- antibody diagnosis
- monoclonal antibodies
- immunoregulatory molecules
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ